Gestational Caloric Restriction Alters Adipose Tissue Methylome and Offspring's Metabolic Profile in a Swine Model

Berta Mas-Parés1, Sílvia Xargay-Torrent1, Gemma Carreras-Badosa1

  • 1Obesity and Cardiovascular Risk in Pediatrics, Girona Biomedical Research Institute (IDIBGI), 17190 Salt, Spain.

Insights

Gestational caloric restriction negatively impacts offspring metabolism and adipose tissue epigenetics. Early metformin intervention shows potential to improve adipocyte morphology and regulate DNA methylation, mitigating adverse effects.

Area of Science:

  • Perinatal programming
  • Epigenetics
  • Metabolic health

Background:

  • Fetal nutrient restriction causes adverse offspring adaptations.
  • Gestational caloric restriction (GCR) impacts offspring development.
  • Epigenetic modifications in adipose tissue are linked to metabolic disease.

Purpose of the Study:

  • Investigate GCR and postnatal metformin effects on swine offspring adipose tissue epigenetics.
  • Assess associations between epigenetic changes and morphometric/metabolic variables.
  • Determine metformin's potential to counteract GCR-induced alterations.

Main Methods:

  • Swine model with GCR (30% food restriction) vs. standard diet.
  • Postnatal treatment with metformin or vehicle during lactation.
  • Analysis of DNA methylation and gene expression in retroperitoneal adipose tissue.
  • Assessment of morphometric and metabolic parameters.

Main Results:

  • GCR impaired offspring metabolic profiles and increased adipose inflammation.
  • GCR altered methylation of metabolism-related genes.
  • Metformin improved adipocyte morphology and regulated methylation in key signaling pathways (atherosclerosis, insulin, fatty acids).
  • Specific gene methylation (FASN, SLC5A10, COL5A1, PRKCZ) correlated with metabolic profiles in GCR offspring.

Conclusions:

  • GCR in pregnancy leads to epigenetic and inflammatory changes in offspring adipose tissue, increasing metabolic abnormality risk.
  • Early metformin administration may modulate adipocyte size and DNA methylation, offering a potential therapeutic strategy.